PureTech Health plc
A clinical-stage biotherapeutics company developing new medicines for devastating diseases.
PRTC | IL
Overview
Corporate Details
- ISIN(s):
- GB00BPVG5C82 (+2 more)
- LEI:
- 213800LVPDNO2Z9T9I39
- Country:
- United States of America
- Address:
- 6 TIDE STREET, 2210 BOSTON
- Website:
- https://puretechhealth.com/
- Sector:
- Manufacturing
Description
PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2017-11-22 08:00 |
PureTech to Present at Piper Jaffray Conference
|
English | 17.5 KB | ||
| 2017-11-20 08:00 |
PRTC's Clinical-Stage Anti-Aging Compound Advances
|
English | 26.1 KB | ||
| 2017-11-09 08:00 |
PRTC to Present at Jefferies 2017 in London
|
English | 17.5 KB | ||
| 2017-11-03 08:00 |
PRTC: Vedanta Gets $5.4M for Antibiotic Resistance
|
English | 31.4 KB | ||
| 2017-11-01 08:00 |
PRTC's Vedanta Licenses Microbiome IO Candidates
|
English | 29.7 KB | ||
| 2017-10-20 14:07 |
Second Price Monitoring Extn
|
English | 7.5 KB | ||
| 2017-10-20 14:02 |
Price Monitoring Extension
|
English | 7.5 KB | ||
| 2017-09-26 09:00 |
PDMR DEALING - PURCHASE OF SHARES
|
English | 20.5 KB | ||
| 2017-09-25 09:00 |
Research Update PRTC Gelesis Shows Efficacy/Safety
|
English | 29.2 KB | ||
| 2017-09-20 09:00 |
PRTC Notes IP For Health Assessments from Speech
|
English | 20.9 KB | ||
| 2017-09-19 09:00 |
PureTech Licenses Milk-Derived Exosome Technology
|
English | 21.7 KB | ||
| 2017-09-15 09:00 |
PDMR DEALING - PURCHASE OF SHARES
|
English | 20.5 KB | ||
| 2017-09-07 19:00 |
Director/PDMR Shareholding
|
English | 21.1 KB | ||
| 2017-09-04 09:00 |
Director/PDMR Shareholding
|
English | 20.9 KB | ||
| 2017-08-31 09:00 |
Total Voting Rights
|
English | 13.5 KB |
Automate Your Workflow. Get a real-time feed of all PureTech Health plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PureTech Health plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PureTech Health plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
